Jun. 23 at 12:54 AM
$HUMA IS MY #1 PICK
$IMRX NEXT AND CHIPS
$SOXL EVENTUALLY
$SOXS HUMA (
$0.83) is in early accumulation with major funds stepping in—Davidson Kempner added +12.7M shares alongside Vanguard, BlackRock, and others building positions. Near-term chop likely
$0.80–
$1.10 (+0–33%), followed by BLA run to
$1.30–
$1.80 (+57–117%). Pre-approval re-rate targets
$1.80–
$3.00 (+117–261%) as institutions scale. Approval phase (2027) supports
$3.00–
$6.00 (+261–622%) on commercialization. Long-term (CABG + platform expansion) unlocks
$6–
$15+ (+622–1700%+). Smart money is early, not all-in—this is positioning before full re-rating. Not investment advice. I EXPECT
$4 WITHIN A YEAR AND
$10 OR MORE IN 3 YEARS
